In the largest randomized trial to date comparing drug-eluting stents (DES) and bare-metal stents (BMS) in saphenous vein graft (SVG) lesions, DES produced lower rates of restenosis and target lesion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results